Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://ipsapp003.lwwonline.com/content/getfile/3183/20/11/abstract.htm

Previous Abstract  | Full Text  | Full Text PDF (248 K)  | References (32)  | Next Abstract

 

Journal of Pediatric Hematology/Oncology 2003; 25(2):134-138

Influenza Immunization Practices Among Pediatric Oncologists

Christopher C. Porter, M.D.; Katherine A. Poehling, M.D., M.P.H.; Rodney Hamilton, M.D.; Haydar Frangoul, M.D.; William O. Cooper, M.D., M.P.H.

Purpose:

To describe the opinions of pediatric oncologists regarding the use of influenza vaccine in children with cancer and to identify factors that influence practitioners' recommendations about influenza vaccine.

Materials and Methods:

A survey was sent to members of the Children's Oncology Group to inquire about their clinical experience and practice setting, opinions regarding the use of the influenza vaccine in children with cancer, and factors that influence their recommendations.

Results:

Of 803 pediatric oncologists identified, 434 (54%) responded. Depending on the type of tumor, 65% to 69% of pediatric oncologists indicated that they routinely recommend influenza vaccine for children being treated for cancer. Respondents were much more likely to recommend influenza vaccine for children with various types of cancer if they indicated that: 1) their practice has guidelines regarding the use of influenza vaccine (odds ratios ranging from 7.2 to 11.7); 2) influenza infection is very significant (odds ratios ranging from 1.4 to 3.7); and 3) influenza vaccine is effective (odds ratios ranging from 7.2 to 14.9).

Conclusions:

The majority of pediatric oncologists routinely recommend influenza vaccine for children being treated for cancer; however, a significant number of pediatric oncologists do not. Clarification of the benefit of influenza vaccine for children with cancer and the institution of practice guidelines may increase the use of the influenza vaccine among pediatric oncologists.

Key Words: Pediatric hematology/oncology; Influenza vaccine; Questionnaire

Submitted for publication July 8, 2002;

accepted October 11, 2002.

From the Department of Pediatrics, Division of Pediatric Hematology/Oncology/BMT, University of Colorado Health Sciences Center, Denver, Colorado (C.P.); and the Department of Pediatrics (R.H.), Department of Pediatrics, Division of Pediatric Hematology/Oncology (H.F.), and Department of Pediatrics, Division of General Pediatrics (K.P., W.C.), Vanderbilt University Medical Center, Nashville, Tennessee, U.S.A.

Address correspondence and reprint requests to Dr. Christopher C. Porter, The Children's Hospital, 1056 East 19th Avenue, B115, Denver, CO 80218 U.S.A. E-mail: porter.christopher@tchden.org.

Journal of Pediatric Hematology/Oncology 2003; 25(2):134-138
All rights reserved

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.